Indian generic drugs maker Dr Reddy's Laboratories posted a narrow miss of quarterly profit expectations on Wednesday, as it ...

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...

As per the latest Enforcement Report of US Food and Drug Administration, the Mumbai-headquartered Sun Pharmaceutical ...

Sun Pharma, Lupin, and Dr Reddy's are recalling various drugs from the US market due to manufacturing issues and product mix-ups, as per the USFDA.

Dr Reddy’s Laboratories invests Rs 565 crore in Russian subsidiary, acquiring 45.19% stake for working capital needs.

Indian pharmaceutical giants Sun Pharma, Lupin and Dr Reddy's Laboratories are recalling drugs from the US market due to ...

Dr Reddy's Laboratories share price gained almost 3% in the morning trades on Thursday post Q1 results that were declared ...

Dr. Reddy’s Laboratories Limited (NYSE:RDY) is one of the Best Indian Stocks to Buy for Next 5 Years. Dr. Reddy’s Laboratories Limited (NYSE:RDY) and Alvotech announced that they have entered into a ...

Sun Pharmaceutical Industries, headquartered in Mumbai, is recalling 5,448 bottles of a generic drug used to treat Attention ...

Dr. Reddy's Laboratories Ltd. closed 10.04% short of its 52-week high of 1,420.20 rupees, which the company achieved on August 21st.